Award

Exercise and senolytics as therapeutic strategies for improving skeletal muscle mass and function in advanced age

Description: With advanced age, there is a loss of muscle mass and function, known as sarcopenia, which can lead to an increased risk of falls, disability, infection, and an overall decline in the quality of life. Exercise is currently the most effective treatment for sarcopenia as it can reduce muscle loss and increase muscle mass and strength. A mechanism of aging is the accumulation of senescent cells, which leads to a reduced ability for tissues to function properly. Senescence is a state that cells can enter that permanently stops cell division while releasing factors that negatively affect nearby cells in the surrounding environment. By eliminating senescent cells, the age-related decline in muscle function may be alleviated. To do so we lean on a new class of drugs that selectively kill senescent cells called senolytics which have been used to improve function in aged tissues. Thus senolytic treatment may be used as a therapeutic strategy to treat skeletal muscle, however, it has yet to be fully investigated. In this study, we aim to determine if exercise and senolytics can be used as an effective treatment to improve muscle function in aging alone or in combination. We will compare biweekly senolytic treatment, 2x/week exercise training program, biweekly senolytic and exercise training program and no treatment in one year old mice for one year. By better understanding the effects senolytics and exercise have on aging, we can develop new strategies to improve muscle function, thus improving the quality of life in the aging population.
Amount: CA$120,000
Funding type: fellowship
Funder scheme: Doctoral Research Award: Canada Graduate Scholarships
Start date: 2024-09-01
End date: 2027-08-31
Investigator: Amanda Johnson (lead)
Institution: McMaster University
Field: Medicine
Funded outputs count: 0
Funder award ID: 193507_1
OpenAlex ID: G1267926993